DK0817637T3 - Synergistiske kombinationer af zidovudin, 1592U89 og 3TC eller FTC - Google Patents

Synergistiske kombinationer af zidovudin, 1592U89 og 3TC eller FTC

Info

Publication number
DK0817637T3
DK0817637T3 DK96911953T DK96911953T DK0817637T3 DK 0817637 T3 DK0817637 T3 DK 0817637T3 DK 96911953 T DK96911953 T DK 96911953T DK 96911953 T DK96911953 T DK 96911953T DK 0817637 T3 DK0817637 T3 DK 0817637T3
Authority
DK
Denmark
Prior art keywords
ftc
zidovudine
synergistic combinations
synergistic
combinations
Prior art date
Application number
DK96911953T
Other languages
Danish (da)
English (en)
Inventor
Clair Martha Heider St
David Walter Barry
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26306774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0817637(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9506490.3A external-priority patent/GB9506490D0/en
Priority claimed from GBGB9506489.5A external-priority patent/GB9506489D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of DK0817637T3 publication Critical patent/DK0817637T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
DK96911953T 1995-03-30 1996-03-28 Synergistiske kombinationer af zidovudin, 1592U89 og 3TC eller FTC DK0817637T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9506490.3A GB9506490D0 (en) 1995-03-30 1995-03-30 Antiviral combinations
GBGB9506489.5A GB9506489D0 (en) 1995-03-30 1995-03-30 Antiviral combinations
PCT/EP1996/001352 WO1996030025A1 (en) 1995-03-30 1996-03-28 Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc

Publications (1)

Publication Number Publication Date
DK0817637T3 true DK0817637T3 (da) 2002-11-11

Family

ID=26306774

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96911953T DK0817637T3 (da) 1995-03-30 1996-03-28 Synergistiske kombinationer af zidovudin, 1592U89 og 3TC eller FTC

Country Status (35)

Country Link
US (1) US6417191B1 (cs)
EP (1) EP0817637B1 (cs)
JP (1) JP2954357B2 (cs)
KR (1) KR100542536B1 (cs)
CN (1) CN1103593C (cs)
AP (1) AP652A (cs)
AT (1) ATE220551T1 (cs)
AU (1) AU715213B2 (cs)
BR (3) BR9607851B1 (cs)
CA (1) CA2216634C (cs)
CZ (1) CZ295940B6 (cs)
DE (3) DE69622386T2 (cs)
DK (1) DK0817637T3 (cs)
EA (1) EA000626B3 (cs)
EE (1) EE04047B1 (cs)
ES (1) ES2179193T3 (cs)
FR (1) FR05C0022I2 (cs)
GE (1) GEP20022647B (cs)
HU (1) HU224010B1 (cs)
IL (1) IL117727A (cs)
LU (1) LU91171I2 (cs)
MX (1) MX9707316A (cs)
MY (1) MY115461A (cs)
NL (1) NL300195I2 (cs)
NO (2) NO313787B1 (cs)
NZ (1) NZ306419A (cs)
OA (1) OA10616A (cs)
PL (1) PL187085B1 (cs)
PT (1) PT817637E (cs)
RO (1) RO117995B1 (cs)
SI (1) SI0817637T1 (cs)
SK (1) SK283825B6 (cs)
TR (1) TR199701074T1 (cs)
UA (1) UA60293C2 (cs)
WO (1) WO1996030025A1 (cs)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1228026A (zh) * 1996-06-25 1999-09-08 葛兰素集团有限公司 用于治疗hiv感染的含有vx478、叠氮胸苷、ftc和/或3tc的复方制剂
US6113920A (en) * 1996-10-31 2000-09-05 Glaxo Wellcome Inc. Pharmaceutical compositions
TW536403B (en) * 1997-03-24 2003-06-11 Glaxo Group Ltd An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
AU769660B2 (en) * 1997-05-17 2004-01-29 Glaxo Group Limited Carbocyclic nucleoside hemisulfate and its use in treating viral infections
GB9709945D0 (en) * 1997-05-17 1997-07-09 Glaxo Group Ltd A novel salt
WO1998052570A1 (en) * 1997-05-17 1998-11-26 Glaxo Group Limited Antiviral combinations containing the carbocyclic nucleoside 1592u89
GB9809213D0 (en) * 1998-04-29 1998-07-01 Glaxo Group Ltd Pharmaceutical compositions
AU4219799A (en) * 1998-05-29 1999-12-13 University Of Florida Combination therapy for treatment of fiv infection
US6875773B1 (en) 1998-05-29 2005-04-05 Ben M. Dunn Combination therapy for treatment of FIV infection
GB9820417D0 (en) * 1998-09-18 1998-11-11 Glaxo Group Ltd Antiviral combinations
US6432966B2 (en) 1999-10-29 2002-08-13 Smithkline Beecham Corporation Antiviral combinations
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
AP2220A (en) * 2001-05-11 2011-03-24 Cipla Medpro Pty Ltd Pharmaceutical composition.
AR040242A1 (es) * 2002-06-04 2005-03-23 Glaxo Group Ltd Composiciones farmaceuticas
US20040224917A1 (en) 2003-01-14 2004-11-11 Gilead Sciences, Inc. Compositions and methods for combination antiviral therapy
JP4485520B2 (ja) 2003-03-24 2010-06-23 エフ.ホフマン−ラ ロシュ アーゲー 逆転写酵素阻害剤としてのベンジル−ピリダジノン類
EP2270511A3 (en) 2003-10-24 2011-08-24 Immunaid Pty Ltd Method of therapy
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
AU2006303368B2 (en) 2005-10-19 2011-05-26 F. Hoffmann-La Roche Ag Non-Nucleoside Reverse Transcriptase Inhibitors
JP5415957B2 (ja) 2006-12-13 2014-02-12 エフ.ホフマン−ラ ロシュ アーゲー 非ヌクレオシド逆転写酵素阻害剤としての2−(ピペリジン−4−イル)−4−フェノキシ−又はフェニルアミノ−ピリミジン誘導体
AU2008213744B2 (en) * 2007-02-09 2013-12-05 Alphapharm Pty Ltd A dosage form containing two or more active pharmaceutical ingredients in different physical forms
WO2010135781A1 (en) 2009-05-27 2010-12-02 Immunaid Pty Ltd Methods of treating diseases
LT3127542T (lt) 2010-01-27 2018-11-26 Viiv Healthcare Company Antivirusinė terapija
HK1220390A1 (zh) 2013-08-29 2017-05-05 Teva Pharmaceutical Industries Ltd. 包括恩曲他滨,替诺福韦,达芦那韦和利托那韦的单位剂型以及包含达芦那韦和利托那韦的单体片剂
WO2015155673A1 (en) 2014-04-08 2015-10-15 Teva Pharmaceutical Industries Ltd Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir
US11311512B2 (en) 2014-08-12 2022-04-26 Monash University Lymph directing prodrugs
US11738087B2 (en) 2015-09-08 2023-08-29 Monash University Lymph directing prodrugs
CA3077739A1 (en) 2017-08-29 2019-03-07 Puretech Lyt, Inc. Lymphatic system-directing lipid prodrugs
US11883497B2 (en) 2017-08-29 2024-01-30 Puretech Lyt, Inc. Lymphatic system-directing lipid prodrugs
US11304954B2 (en) 2017-12-19 2022-04-19 Puretech Lyt, Inc. Lipid prodrugs of mycophenolic acid and uses thereof
US11608345B1 (en) 2017-12-19 2023-03-21 Puretech Lyt, Inc. Lipid prodrugs of rapamycin and its analogs and uses thereof
JP2023514147A (ja) 2020-02-05 2023-04-05 ピュアテック・エル・ワイ・ティ・インコーポレイテッド 神経ステロイドの脂質プロドラッグ

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
US5047407A (en) 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5122517A (en) 1988-06-10 1992-06-16 Regents Of The University Of Minnesota Antiviral combination comprising nucleoside analogs
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
US5204466A (en) 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
GB9104740D0 (en) * 1991-03-06 1991-04-17 Wellcome Found Antiviral nucleoside combination
DE69206876T3 (de) * 1991-05-16 2004-08-12 Glaxo Group Ltd., Greenford Nukleosidanalogen enthaltende Antiviren-Zubereitungen
ES2138624T3 (es) * 1992-05-13 2000-01-16 Wellcome Found Combinaciones terapeuticas.
US5723490A (en) 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
GB9417249D0 (en) 1994-08-26 1994-10-19 Wellcome Found A novel salt
US5869461A (en) 1995-03-16 1999-02-09 Yale University Reducing toxicity of L-nucleosides with D-nucleosides
CN1306430A (zh) 1996-06-25 2001-08-01 葛兰素集团有限公司 用于治疗hiv感染的含有vx478、叠氮胸苷和/或1592u89的复方制剂
CN1228026A (zh) 1996-06-25 1999-09-08 葛兰素集团有限公司 用于治疗hiv感染的含有vx478、叠氮胸苷、ftc和/或3tc的复方制剂
DE10226522A1 (de) * 2002-06-14 2003-12-24 Degussa Verwendung von Übergangsmetallkomplexen mit stickstoffhaltigen mehrzähnigen Liganden als Bleichkatalysator und Bleichmittelzusammensetzung

Also Published As

Publication number Publication date
SI0817637T1 (en) 2002-10-31
IL117727A0 (en) 1996-07-23
BR9607851A (pt) 1998-07-21
EE04047B1 (et) 2003-06-16
CZ295940B6 (cs) 2005-12-14
NO2005014I1 (no) 2005-06-06
JPH10511682A (ja) 1998-11-10
AP9701089A0 (en) 1997-10-31
NO2005014I2 (no) 2008-02-11
LU91171I9 (cs) 2018-12-28
BRPI9607851B8 (pt) 2019-11-05
CN1103593C (zh) 2003-03-26
KR100542536B1 (ko) 2006-03-23
NO974510D0 (no) 1997-09-29
NL300195I2 (nl) 2005-11-01
OA10616A (en) 2001-03-15
GEP20022647B (en) 2002-03-25
DE122005000029I1 (de) 2005-10-06
CZ309097A3 (cs) 1998-05-13
DE122005000029I2 (de) 2006-04-27
NO974510L (no) 1997-09-29
DE69622386D1 (de) 2002-08-22
UA60293C2 (uk) 2003-10-15
PL187085B1 (pl) 2004-05-31
HUP9801571A3 (en) 2001-04-28
AU5497296A (en) 1996-10-16
ES2179193T3 (es) 2003-01-16
KR19980703420A (ko) 1998-11-05
FR05C0022I2 (cs) 2005-10-21
HUP9801571A2 (hu) 1999-01-28
EP0817637A1 (en) 1998-01-14
EA000626B1 (ru) 1999-12-29
EA000626B3 (ru) 2016-04-29
EP0817637B1 (en) 2002-07-17
CA2216634C (en) 2004-07-20
SK283825B6 (sk) 2004-02-03
WO1996030025A1 (en) 1996-10-03
BR9607851B1 (pt) 2009-01-13
NL300195I1 (nl) 2005-08-01
TR199701074T1 (xx) 1998-02-21
RO117995B1 (ro) 2002-12-30
CN1185110A (zh) 1998-06-17
EA199700203A1 (ru) 1998-02-26
US6417191B1 (en) 2002-07-09
NZ306419A (en) 2000-01-28
PT817637E (pt) 2002-11-29
SK129597A3 (en) 1998-07-08
EE9700240A (et) 1998-04-15
FR05C0022I1 (cs) 2005-06-10
MX9707316A (es) 1997-11-29
PL322532A1 (en) 1998-02-02
CA2216634A1 (en) 1996-10-03
IL117727A (en) 1999-11-30
AU715213B2 (en) 2000-01-20
JP2954357B2 (ja) 1999-09-27
MY115461A (en) 2003-06-30
DE69622386T2 (de) 2003-02-13
LU91171I2 (fr) 2005-07-04
NO313787B1 (no) 2002-12-02
ATE220551T1 (de) 2002-08-15
BRPI9612992B1 (pt) 2020-08-04
AP652A (en) 1998-06-19
HU224010B1 (hu) 2005-04-28
HK1009401A1 (en) 1999-09-10

Similar Documents

Publication Publication Date Title
DK0817637T3 (da) Synergistiske kombinationer af zidovudin, 1592U89 og 3TC eller FTC
NO983965D0 (no) Polymer-organoleire-kompositter og deres fremstilling
NO972983D0 (no) Sulfonamider og deres anvendelse
DK0832104T3 (da) Dolastatinderivater, deres fremstilling og anvendelse
DK0832082T3 (da) N-heteroaryl-pyridinsulfonamidderivater og deres anvendelse som endotelinantagonister
NO964958D0 (no) Aluminium-scandiumlegeringer og deres anvendelse
DK0906292T3 (da) Triazolylmercaptider og deres anvendelse som mikrobicider
NO933434D0 (no) Piperidinderivater, deres fremstilling og anvendelse
DK1019358T3 (da) 3,3-diarylpropylaminer, deres anvendelse og fremstilling
ATE357459T1 (de) Antikörper gegen mensliches il-12
NO20006488D0 (no) Sammensetning og anvendelse
DK1112003T3 (da) Ny sammensætning og anvendelse
DK0770059T3 (da) Substituerede benzamidiner, deres fremstilling og deres anvendelse som lægemidler
DK0804078T3 (da) Sammensætning og anvendelse deraf
NO995513L (no) N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK-
NO986034D0 (no) Kombinasjoner omfattende VX 478, ZidovudÞn, FTC og/eller 3TC for anvendelse
DK0898566T3 (da) Substituerede benzylaminer og anvendelse deraf til behandling af depression
NO963723L (no) Flytepunktnedsettende tilsetningsstoffer og deres anvendelse
DK60893D0 (da) Piperidinderivater, deres fremstilling og anvendelse
NO933435D0 (no) Piperidinderivater, deres fremstilling og anvendelse
DK278289A (da) Ekspressionsvektorer, deres fremstilling og anvendelse til fremstilling af ufusionerede proteiner i mikroorganismer
DK0776899T3 (da) Mellemprodukter og deres anvendelse til fremstilling af N,N'-forbundne bisindolylmaleimider
NO972821D0 (no) 1-C-perfluoralkylglycosider, deres fremstilling og anvendelse
NO986035D0 (no) Kombinasjoner omfattende VX478, zidovudin og/eller 1592U89 for anvendelse i
NO982242D0 (no) Heparinanaloge kopolymerer, deres fremstilling og anvendelse